Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1992 Feb;36(2):458–462. doi: 10.1128/aac.36.2.458

Efficacy of ticarcillin-clavulanic acid for treatment of experimental Staphylococcus aureus endocarditis in rats.

E J Catherall 1, V Gillon 1, S Hurn 1, R Irwin 1, L Mizen 1
PMCID: PMC188457  PMID: 1605610

Abstract

The efficacy of ticarcillin-clavulanic acid was compared with the efficacies of standard antistaphylococcal agents (flucloxacillin, oxacillin, nafcillin, and vancomycin) and ticarcillin in an experimental model of Staphylococcus aureus endocarditis. Therapy was either initiated soon (8 h) after infection, when numbers of bacteria in aortic valve vegetations were relatively low (approximately 6 to 8 log10 CFU/g), or delayed until 24 h after infection, when the vegetations usually contained greater than 9 log10 CFU/g. Doses of the antibiotic were selected to produce peak concentrations in rat serum similar to those achievable in humans after administration of parenteral therapeutic doses. Ticarcillin-clavulanic acid was more effective overall than ticarcillin alone against endocarditis caused by beta-lactamase-producing strains of S. aureus, illustrating the beta-lactamase-inhibitory activity of clavulanic acid in vivo. Ticarcillin-clavulanic acid was as effective as the standard antistaphylococcal beta-lactam agents flucloxacillin, oxacillin, and nafcillin in these infections, whereas vancomycin was generally less active. These results illustrate the clinical potential of ticarcillin-clavulanic acid in the prophylaxis or therapy of severe staphylococcal infections.

Full text

PDF
458

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bayer A. S., Lam K. Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations. J Infect Dis. 1985 Jan;151(1):157–165. doi: 10.1093/infdis/151.1.157. [DOI] [PubMed] [Google Scholar]
  2. Boon R. J., Beale A. S., Sutherland R. Bactericidal effects of ticarcillin-clavulanic acid against beta-lactamase-producing bacteria in vivo. Antimicrob Agents Chemother. 1986 May;29(5):838–844. doi: 10.1128/aac.29.5.838. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cantoni L., Glauser M. P., Bille J. Comparative efficacy of daptomycin, vancomycin, and cloxacillin for the treatment of Staphylococcus aureus endocarditis in rats and role of test conditions in this determination. Antimicrob Agents Chemother. 1990 Dec;34(12):2348–2353. doi: 10.1128/aac.34.12.2348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cantoni L., Wenger A., Glauser M. P., Bille J. Comparative efficacy of amoxicillin-clavulanate, cloxacillin, and vancomycin against methicillin-sensitive and methicillin-resistant Staphylococcus aureus endocarditis in rats. J Infect Dis. 1989 May;159(5):989–993. doi: 10.1093/infdis/159.5.989. [DOI] [PubMed] [Google Scholar]
  5. Chambers H. F., Hackbarth C. J., Drake T. A., Rusnak M. G., Sande M. A. Endocarditis due to methicillin-resistant Staphylococcus aureus in rabbits: expression of resistance to beta-lactam antibiotics in vivo and in vitro. J Infect Dis. 1984 Jun;149(6):894–903. doi: 10.1093/infdis/149.6.894. [DOI] [PubMed] [Google Scholar]
  6. Chambers H. F., Sachdeva M., Kennedy S. Binding affinity for penicillin-binding protein 2a correlates with in vivo activity of beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus. J Infect Dis. 1990 Sep;162(3):705–710. doi: 10.1093/infdis/162.3.705. [DOI] [PubMed] [Google Scholar]
  7. Chandrasekar P. H., Levine D. P., Price S., Rybak M. J. Comparative efficacies of imipenem-cilastatin and vancomycin in experimental aortic valve endocarditis due to methicillin resistant Staphylococcus aureus. J Antimicrob Chemother. 1988 Apr;21(4):461–469. doi: 10.1093/jac/21.4.461. [DOI] [PubMed] [Google Scholar]
  8. Davey P. G., Main J., Scott A. C. An open study of Timentin for the initial treatment of serious infections. J Antimicrob Chemother. 1986 May;17 (Suppl 100):161–168. doi: 10.1093/jac/17.suppl_c.161. [DOI] [PubMed] [Google Scholar]
  9. Durack D. T., Beeson P. B. Experimental bacterial endocarditis. I. Colonization of a sterile vegetation. Br J Exp Pathol. 1972 Feb;53(1):44–49. [PMC free article] [PubMed] [Google Scholar]
  10. Eykyn S. J. The treatment of staphylococcal endocarditis. J Antimicrob Chemother. 1987 Sep;20 (Suppl A):161–171. doi: 10.1093/jac/20.suppl_a.161. [DOI] [PubMed] [Google Scholar]
  11. Faville R. J., Jr, Zaske D. E., Kaplan E. L., Crossley K., Sabath L. D., Quie P. G. Staphylococcus aureus endocarditis. Combined therapy with vancomycin and rifampin. JAMA. 1978 Oct 27;240(18):1963–1965. doi: 10.1001/jama.240.18.1963. [DOI] [PubMed] [Google Scholar]
  12. Frimodt-Møller N., Espersen F., Rosdahl V. T. Antibiotic treatment of Staphylococcus aureus endocarditis. A review of 119 cases. Acta Med Scand. 1987;222(2):175–182. doi: 10.1111/j.0954-6820.1987.tb10656.x. [DOI] [PubMed] [Google Scholar]
  13. Gentry L. O., Macko V., Lind R., Heilman A. Ticarcillin plus clavulanic acid (Timentin) therapy for osteomyelitis. Am J Med. 1985 Nov 29;79(5B):116–121. doi: 10.1016/0002-9343(85)90142-1. [DOI] [PubMed] [Google Scholar]
  14. Gopal V., Bisno A. L., Silverblatt F. J. Failure of vancomycin treatment in Staphylococcus aureus endocarditis. In vivo and in vitro observations. JAMA. 1976 Oct 4;236(14):1604–1606. [PubMed] [Google Scholar]
  15. Graninger W., Kurz R., Schneeweiss B., Janata O. Management and prevention of infections due to gram-positive cocci in intensive care units. Br J Clin Pract Suppl. 1988 Feb;57:91–99. [PubMed] [Google Scholar]
  16. Jackson M. A., Hicks R. A. Vancomycin failure in staphylococcal endocarditis. Pediatr Infect Dis J. 1987 Aug;6(8):750–752. doi: 10.1097/00006454-198708000-00011. [DOI] [PubMed] [Google Scholar]
  17. Karchmer A. W. Staphylococcal endocarditis. Laboratory and clinical basis for antibiotic therapy. Am J Med. 1985 Jun 28;78(6B):116–127. doi: 10.1016/0002-9343(85)90374-2. [DOI] [PubMed] [Google Scholar]
  18. Reading C., Cole M. Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus. Antimicrob Agents Chemother. 1977 May;11(5):852–857. doi: 10.1128/aac.11.5.852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Rolinson G. N. Beta-lactam antibiotics. J Antimicrob Chemother. 1986 Jan;17(1):5–36. doi: 10.1093/jac/17.1.5. [DOI] [PubMed] [Google Scholar]
  20. Sande M. A., Johnson M. L. Antimicrobial therapy of experimental endocarditis caused by Staphylococcus aureus. J Infect Dis. 1975 Apr;131(4):367–375. doi: 10.1093/infdis/131.4.367. [DOI] [PubMed] [Google Scholar]
  21. Small P. M., Chambers H. F. Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Antimicrob Agents Chemother. 1990 Jun;34(6):1227–1231. doi: 10.1128/aac.34.6.1227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Sutherland R., Beale A. S., Boon R. J., Griffin K. E., Slocombe B., Stokes D. H., White A. R. Antibacterial activity of ticarcillin in the presence of clavulanate potassium. Am J Med. 1985 Nov 29;79(5B):13–24. doi: 10.1016/0002-9343(85)90124-x. [DOI] [PubMed] [Google Scholar]
  23. Swanberg L., Tuazon C. U. Rifampin in the treatment of serious staphylococcal infections. Am J Med Sci. 1984 May-Jun;287(3):49–54. doi: 10.1097/00000441-198405000-00018. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES